No profile data available.
Purple Biotech Ltd (PPBT) is a healthcare company in the additional cancer treatment drugs industry, based in Rehovot, Israel, with about 10 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$26.39 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $2.16 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States.
Purple Biotech reported $0 in revenue for fiscal year 2025. In Q2 2026 revenue was $0.
$2.16 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional cancer treatment drugs) include Kairos Pharma, Ltd. (KAPA), BioAtla, Inc. (BCAB), Genprex, Inc. (GNPX), Carisma Therapeutics, Inc. (CARM).